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Abstract
Background and purpose: The purpose of this work is to summarize cardiovascular magnetic resonance (CMR)
research trends and highlights presented at the annual Society for Cardiovascular Magnetic Resonance (SCMR)
scientific sessions over the past 20 years.
Methods: Scientific programs from all SCMR Annual Scientific Sessions from 1998 to 2017 were obtained. SCMR
Headquarters also provided data for the number and the country of origin of attendees and the number of accepted
abstracts according to type. Data analysis included text analysis (key word extraction) and visualization by ‘word clouds’
representing the most frequently used words in session titles for 5-year intervals. In addition, session titles were sorted
into 17 major subject categories to further evaluate research and clinical CMR trends over time.
Results: Analysis of SCMR annual scientific sessions locations, attendance, and number of accepted abstracts demonstrated
substantial growth of CMR research and clinical applications. As an international field of study, significant growth of CMR
was documented by a strong increase in SCMR scientific session attendance (> 500%, 270 to 1406 from 1998 to 2017,
number of accepted abstracts (> 700%, 98 to 701 from 1998 to 2018) and number of international participants (42–415%
increase for participants from Asia, Central and South America, Middle East and Africa in 2004–2017). ‘Word clouds’ based
evaluation of research trends illustrated a shift from early focus on ‘MRI technique feasibility’ to new established techniques
(e.g. late gadolinium enhancement) and their clinical applications and translation (key words ‘patient’, ‘disease’) and more
recently novel techniques and quantitative CMR imaging (key words ‘mapping’, ‘T1’, ‘flow’, ‘function’). Nearly every topic
category demonstrated an increase in the number of sessions over the 20-year period with ‘Clinical Practice’ leading all
categories. Our analysis identified three growth areas ‘Congenital’, ‘Clinical Practice’, and ‘Structure/function/flow’.
Conclusion: The analysis of the SCMR historical archives demonstrates a healthy and internationally active field of study
which continues to undergo substantial growth and expansion into new and emerging CMR topics and clinical
application areas.
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Background
On February 3, 2017, the Society for Cardiovascular
Magnetic Resonance (SCMR) celebrated its 20th
Annual Scientific Sessions in Washington D.C. Over
the past 20 years, the field of cardiovascular magnetic
resonance (CMR) has witnessed major advancements
in data acquisition speed, image quality and develop-
ment of novel imaging techniques [1–11], application
of CMR to a broader range of cardiovascular diseases
[12–25], and the incorporation into consensus
statements [26–34] and clinical practice guidelines
[26, 35–39].
On the direction of the SCMR Executive Committee,
the SCMR Science Committee sought to evaluate
research trends in CMR by evaluating session titles from
SCMR Annual Scientific Sessions Programs over the
past 20 years. Our goal was to track the number of ab-
stracts and scientific contributions, analyze the evolution
of research trends and hot topics, and identify the
changes in main clinical focus areas and application
areas over the past 20 years.
Methods
Data acquisition
Scientific programs from all SCMR Annual Scientific
Sessions from 1998 to 2017 were obtained from the
SCMR Headquarters Office and SCMR members.
Digital program files were available for 2000–2017,
while programs of the 1998 and 1999 annual scientific
sessions were only available in paper form. SCMR
Headquarters also provided data for number of
attendees, country of origin of attendees (only
available for 2004–2017) and number of accepted
abstracts according to type (available for 1998–2018):
oral, poster, walking poster, e-poster, moderated
poster, and pre-conference workshop. In addition, the
ratio of attendance / (number of accepted abstracts)
was calculated.
Data analysis
Session titles were abstracted from all programs and
collated by year. Digital text analysis and visualization
was performed using voyant-tools.org. The tool was
used to visualize research and clinical trends by creat-
ing ‘word clouds’ representing the most frequently
used key words in session titles in 5-year intervals.
Common key words found in many session titles such
as ‘MRI’, ‘CMR’, ‘cardiac’, and ‘MR’ were excluded from
the analysis. To further evaluate research and clinical
CMR trends over time, session titles were analyzed
and subsequently manually sorted into 17 major
subject categories. Title counts were grouped into
four-year time periods: 1998–2001, 2002–2005,
2006–2009, 2010–2013, 2014–2017. The evolution of
these major subject categories was sub-divided into
“super growth” (an absolute increase of ≥ 8 sessions
from the first time period to the last), and “strong
growth” (an absolute increase of ≥ 4 sessions from the
first time period to the last). In addition, new cat-
egories were defined as those that did not have any
sessions in the first time period.
Results
SCMR annual scientific sessions 1998–2017: Location,
attendance, abstracts
The dynamics and substantial growth of CMR
research and applications are reflected in the evolu-
tion of SCMR annual scientific sessions locations and
duration (Table 1), scientific session title pages from
1998 to 2017 (Fig. 1), and by the overall annual
scientific sessions attendees, number of accepted
abstracts over the past 20 years, and attendee /
accepted abstracts ratio (Table 2 and Figs. 2 and 3).
Figure 1 shows side-by-side comparisons of selected
title pages of all 20 past SCMR annual scientific
sessions. Style and illustrations reflect choices and
preferences by the local organizers, scientific program
committee, and SCMR board at the time of the
annual scientific sessions. Nevertheless, tracking the
temporal evolution of CMR images used for each title
page provide an illustration of a trend from basic to
advanced CMR methods.
Significant growth of CMR research and clinical
applications is corroborated by the consistent and
strong increase of SCMR scientific session attendance
and abstracts which document a > 500% growth in
attendance (270 attendees in 1999 to 1406 in 2017)
and a > 700% increase in the number of accepted
abstracts (98 in 1998 to 701 in 2018). A more
detailed breakdown of annual scientific sessions
abstracts (oral and poster presentations) according to
type is shown in Fig. 3 and illustrates that the grow-
ing number of contributions led to the creation of
new categories (walking poster, e-poster, moderated
poster) in recent years. As expected, a strong and
significant relationship exists between the number
SCMR annual scientific sessions attendees and
abstract submissions (Fig. 3b). Interestingly, the
attendance / accepted abstracts ratio varied consider-
ably during early years (range from 1.1 to 4.5) but
has stabilized over the past 7 years, ranging between
2.0 and 2.5.
Table 2 shows a detailed breakdown of SCMR
annual scientific sessions attendees by country of
origin over the past 14 years (2004–2017). There was
a steady overall increase in international participation
at the SCMR annual scientific sessions if average
attendance in early (2004–2010) and more recent
Lee et al. Journal of Cardiovascular Magnetic Resonance  (2018) 20:8 Page 2 of 11
(2010–2017) time periods for the available data are
compared; 570 to 641 (12% increase) for attendees
from the United States and Canada, 315 to 450 for
Europe (43% increase), 29 to 41 for Asia (42%
increase), 13 to 19 for Central and South America
(45% increase), 9 to 17 for Australia and New
Zealand (89% increase), and 3 to 15 for Africa and
Middle East (415% increase). As expected, SCMR
annual scientific sessions held in Europe (2004, 2007,
2011, 2015) were characterized by an increase of
European attendees compared to SCMR scientific
sessions in the United States (see Table 2).
Research and clinical trends: Key Word Extraction
& Word Clouds
Word clouds summarizing the results of key word
extraction from SCMR annual scientific sessions titles
are shown in Fig. 4. Results represent the most
frequently used words in session titles (increase size
indicated more frequent use) for four 5-year periods.
Comparison of the temporal evolution of the word
clouds over the past 20 years illustrates a topical shift
from ‘CMR centric’ to ‘disease centric’. Initially, in
years 1–5 (Fig. 4a) CMR techniques and their feasibil-
ity, the exploration of different application areas, and
questions related to reimbursement were at the center
of the SCMR annual scientific sessions. Subsequently,
prominent key words such as ‘ischemic’ and ‘enhance-
ment’ document the increasing importance of late
gadolinium enhancement (Fig. 4b and c). In the past
10 years (Fig. 4c and d), the focus has shifted to clin-
ical applications and translation (key words ‘patient’,
‘disease’, ‘congenital’, are more central). Finally, during
the last 5 years (Fig. 4d), the corresponding word
cloud reveals a renewed interest in novel techniques
and quantitative CMR imaging techniques (more
apparent role of key words ‘mapping’, ‘T1’, ‘flow’,
‘function’).
CMR research trends and highlights at SCMR scientific
sessions over the past 20 Years
The number of sessions within all major subject
categories over the past 20 years are depicted in
Fig. 5a. Between the first time period (1998–2001)
and the last (2014–2017), there was an increase in
the number of sessions for every category except
Table 1 SCMR scientific session duration, annual scientific sessions location, and number of annual scientific sessions attendees
1998–2018
SCMR annual scientific sessions
Year Duration [Days] Location - City Location - Country Attendance
1998 3 Atlanta, Georgia USA N/A
1999 3 Atlanta, Georgia USA 270
2000 3 Atlanta, Georgia USA 291
2001 3 Atlanta, Georgia USA 515
2002 3 Lake Buena Vista, Florida USA 704
2003 3 Orlando, Florida USA 850
2004 3 Barcelona Spain 678
2005 3 San Francisco, California USA 940
2006 3 Miami, Florida USA 824
2007 3 Rome Italy 879
2008 4 Los Angeles, California USA 1107
2009 4 Orlando, Florida USA 1074
2010 4 Phoenix, Arizona USA 1150
2011 4 Nice France 1117
2012 4 Orlando, Florida USA 1258
2013 5 San Francisco, California USA 1183
2014 4 New Orleans, Louisiana USA 1226
2015 4 Nice France 1451
2016 4 Los Angeles, California USA 1305
2017 4 Washington DC USA 1406
2018 4 Barcelona Spain N/A
DC District of Columbia, USA United States of America
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metabolism. The subject categories Clinical Practice,
Congenital, Imaging Techniques, Heart Failure/Car-
diomyopathy, and Structure/Function/Flow demon-
strated “super growth” (Fig. 5b). The largest increase
was seen in Congenital. Clinical practice had the most
sessions in four of the five time periods. This
category included sessions focusing on clinical cases,
career development, global CMR, efficiency, safety,
and cost. The category Structure/Function/Flow which
has traditionally few sessions experienced “super
growth” in the last time period due to sessions on
strain, diastolic function, the right ventricle, and 4D
flow. The subject categories Ischemic Heart Disease,
Clinical Trials/Outcomes, Coronary/Vascular, and
Basic/Translational demonstrated “strong growth”
(Fig. 5c).
New categories (those that did not have any sessions
in the first time period) include Electrophysiology,
Tissue Characterization, Analysis/Post-processing,
Interventional, and Clinical Application to Special
Groups (Fig. 5d). This last category includes titles such
as “Phenotyping and Risk Stratification in Hypertrophic
Cardiomyopathy”, “Assessing the Hematology/Oncol-
ogy Patient”, and “Cardiovascular Disease in Women –
CMR’s Essential Role”.
Case sessions also saw significant growth in number
and sophistication. From 1998 to 2001 there was a
single case session offered, “Clinical Case Review
Session: Bring Your Own”. From 2014 to 2017, there
were 39 case sessions offered, including a live inter-
ventional CMR heart catheterization case presented
by Children’s National Medical Center at the most
recent SCMR annual scientific sessions in 2017. The
first SCMR live case (real-time CMR-guided cardiac
catheterization in an atrial septal defect patient) was
a unique experience for the SCMR audience and a
milestone in the history of the SCMR annual scien-
tific sessions. SCMR attendees were provided with the
opportunity to watch a clinical CMR catheterization
program live in operation and recognize potential
benefits of interventional CMR for pediatric and adult
patients.
Fig. 1 SCMR scientific sessions title pages from 1998 to 2017 illustrating a trend from basic to advanced CMR methods
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Discussion
The results of our analysis of SCMR annual scientific
sessions attendance, number and type of abstracts, as
well as CMR research and application trends clearly
demonstrated a healthy and internationally active field
of study which continues to undergo substantial
growth and expansion utilizing new and emerging
CMR techniques to answer a broadening array of
clinical questions. Changes in annual scientific
sessions location and annual scientific sessions
duration summarized in Table 1 are clear indications
of CMR as a growing and international field of study.
Initially varying attendees to accepted abstract ratio
has stabilized in recent years above 2 indicating a
strong and consistent interest in the SCMR annual
scientific sessions also for clinicians and scientists
who did not submit an abstract. These findings are
supported by our key word extraction analysis which
Fig. 2 20-year evolution of SCMR annual scientific session attendance and number of accepted abstracts to be presented at the SCMR scientific
sessions. Sustained growths of both annual scientific sessions attendance and scientific contributions are clearly evident. The attendance number
of the 2018 meeting were not available at the time of this analysis
Fig. 3 a Changes in number of accepted abstracts by type over the past 20 years. b Relationship between number of SCMR annual scientific
session attendees and number of accepted abstracts. c Development of ratio of attendance vs. accepted abstract over the past 20 years
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illustrated a shift from early focus on ‘MRI techniques
and ‘feasibility’ to patient centered clinical translation
and more recently novel techniques and quantitative
CMR imaging. These changes were accompanied by a
dramatic increase in the number of sessions from 46
in 1998–2001 to 168 in 2014–2017.
Nearly every topic category demonstrated an
increase in the number of sessions from the first time
period to the last. Clinical Practice led all categories
in four of the five time periods. The top three growth
areas were Congenital, Clinical Practice, and Struc-
ture/function/flow. In many sessions, growth mirrored
the development of new imaging techniques or ther-
apies. Tissue characterization has seen substantial
growth since mapping techniques have become widely
available. The advent of percutaneous valve tech-
niques has coincided with the emergence of sessions
dedicated to valve disease. Arrhythmias and CMR
used to be mutually exclusive terms, but with real
time techniques and recognition of the utility of CMR
for defining the substrate for arrhythmias this area
has blossomed. The “super growth” in the congenital
category is not surprising, given the increasing role of
CMR in this growing patient population. The category
“Clinical Application to Special Groups” illustrates the
growing application of CMR beyond traditional
atherosclerotic coronary and vascular disease.
Conclusion
We’ve seen the programs evolve from very broad
sessions with a focus on development and validation,
to a wide breadth of sessions that build upon the past
and focus increasingly on specific applications to
patient scenarios and groups where CMR might
Fig. 4 Word clouds visualizing the frequency of words used in SCMR scientific session titles over the past 20 years. Session titles were grouped in
5-year intervals and represent most frequently used words in SCMR session titles from 1998 to 2002 (a), 2003–2007 (b), 2008–2012 (c), and 2013–2017
(d). Word clouds were created using Voyant Tools (http://voyant-tools.org/)
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impact clinical care and practice guidelines. In this
context, a continued collaboration between non-
clinician PhD scientists and engineers and physician
researchers and clinicians coupled with interactions
with other clinically oriented societies will be critical
for the continued success of CMR. The evolution of
sessions at the SCMR annual scientific sessions mir-
rors the growth and maturation of the science and
clinical practice of CMR over the past 20 years.
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Fig. 5 a Number of SCMR scientific session titles within major subject categories - trends over 20 years. b SCMR scientific session subject categories
demonstrating “Super Growth” – defined as absolute growth ≥ 8 session titles over a 20-year time span. c SCMR scientific session subject categories
demonstrating “Growth” – defined as absolute growth ≥ 4 session titles over a 20-year time span. d Several SCMR scientific session subject categories
did not exist in the first time period, but exhibited significant growth in recent years
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